3 research outputs found
Additional file 1: of GWAS-identified CCR1 and IL10 loci contribute to M1 macrophage-predominant inflammation in Behçet’s disease
Figure S1. Comparison of phenotypic features and cytokine profiles between M1 and M2 cultured cells. Figure S2. eQTL effect of rs7616215 on CCR2 and CCR1. Figure S3. Detailed results of chemotaxis of M2 Mφ toward various concentrations of MIP-1α. Figure S4. Differences in CCR1 positivity (fluorescence-activated cell sorting) between treatments. a Biologics. b Colchicine. c Prednisolone. Figure S5. The number of differentiated Mφ in vitro in HC and BD. Figure S6. eQTL effect of rs1518111 on IL-10 protein and mRNA. Figure S7. Schema showing our proposed immunological responses in BD. Table S1. Characteristics of patients with BD who participated in the study. Table S2. Characteristics of HC study participants. (DOCX 9663 kb
Additional file 2: Table S2. of Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study
Phenotype of patients with BD treated with biologic agents. (DOC 29 kb
Additional file 3: Table S3. of Continuous evolution of clinical phenotype in 578 Japanese patients with Behçet’s disease: a retrospective observational study
Rate of therapeutic agents use in groups with different date of onset. (DOC 31 kb